We talked to experts in obesity, tobacco, artificial intelligence, HIV, TB and the National Health Insurance NHI to find out what we can expect and what we cant this year.
The breakthrough six-monthly HIV prevention injection will roll out in April, as we continue to figure out how to deal with the US funding cuts.
AI is showing great promise, and TB screening is one place it could help in South Africa, where drug resistance is climbing.
South Africas first clinical guidelines on treating adult obesity has recommendations on anti-obesity drugs like Ozempic. But they remain unaffordable to nearly everyone.
The long-awaited NHI is law, but is facing nine court challenges. Will this block the roll-out of the scheme indefinitely?
Tobacco legislation seems poised to pass. But its unlikely to look like the current draft.
Intodays newsletter, Tanya Pampalone shares what experts have to say about some of the most pressing health issues this year. Sign up for our newsletter today.
South Africa is a study in contrasts. And the 2026 public health agenda is no exception.
Breakthrough HIV prevention medicine has arrived alongside US funding cuts. AI could revolutionise TB screening but drug resistance is climbing. New obesity drugs have launched but are unaffordable to nearly everyone. National Health Insurance NHI is law but is facing nine court challenges which may kill it. And tobacco legislation advances maybe.
